Sampre Nutritions Ltd (SAMPRE) — shareholding pattern, promoter holding, financials and share price
About Sampre Nutritions Ltd (SAMPRE)
Sampre Nutritions Ltd operates in the Packaged Foods industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as SAMPRE and on the BSE under scrip code 530617. Its ISIN is INE375C01022.
Incorporated in 1991, Sampre Nutrition Ltd is in the business of manufacturing sugar boiled candies & toffees. [1]
Sampre Nutritions Ltd. specializes in manufacturing sugar candies, including various branded products like Dairy Milk Eclairs and jelly cups. The company serves notable clients such as Cadbury India Ltd (now Mondelez India Foods) and has a strong contract manufacturing presence.
In 2022, Sampre Nutritions expanded its production capacity, becoming the exclusive partner for Mondelez India for Eclairs in both domestic and export markets, bolstering its strategic positioning.
Listed peers in Packaged Foods: SSMD Agrotech India Ltd, Ceeta Industries Ltd, Italian Edibles Ltd, Anjani Foods Ltd, Dangee Dums Ltd, Ruparel Food Products Ltd.
Valuation & Returns
10 Jul 2026At ₹5.84 a share on 10 Jul 2026, Sampre Nutritions Ltd (SAMPRE) was valued at a price-to-earnings ratio of 16.81x against an industry P/E of 45.12x and a price-to-book of 0.61x on a book value of ₹9.57 per share as of Mar 2025. Solomo computes return on equity of 3.63% and return on capital employed of 3.36% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 16.81x
- Industry P/E
- 45.12x
- P/B
- 0.61x
- EPS (TTM)
- ₹0.35
- Book value / share
- ₹9.57
- ROE
- 3.63%
- ROCE
- 3.36%
- ROA
- 2.86%
- Debt / equity
- 0.19x
- Dividend yield
- 0%
- EBITDA margin
- 13.75%
- 52-week range
- ₹5.84 – ₹42.33
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Sampre Nutritions Ltd (SAMPRE) reported revenue of ₹43.35 crore, net profit of ₹3.08 crore and earnings per share of ₹0.32. That compares with revenue of ₹25.12 crore and net profit of ₹-7.67 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹15.1 crore and net profit ₹1.35 crore (consolidated).
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue (₹ cr) | 37.11 | 25.15 | 25.12 | 43.35 |
| Net profit (₹ cr) | 0.35 | 0.23 | -7.67 | 3.08 |
| EPS (₹) | 0.13 | 0.08 | -0.91 | 0.32 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -6.29% | 0.22% | 2.80% | -0.12% |
| Stock price CAGR | -7% | 10% | -30% | -35% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 14.04% of Sampre Nutritions Ltd (SAMPRE) (unchanged from the previous quarter). Market capitalisation was ₹55 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: WAVE CAPITAL LTD 9.42%, BEACON STONE CAPITAL VCC - BEACON STONE I FCCB 9.16%, NOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONE 7.1%, RAVI CHANDER RAO ANNAMANENI 2.74%, CHESHTA BATRA 2.11%, NITIN SHARMA 2.11%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 14.04% | - | - | - | 85.96% |
| Mar 2026 | 14.04% | - | 0.43% | - | 85.96% |
| Dec 2025 | 15.26% | - | - | - | 84.74% |
| Sep 2025 | 12.11% | - | - | - | 87.89% |
| Jun 2025 | 12.11% | - | - | - | 87.89% |
| Mar 2025 | 14.16% | - | - | - | 85.84% |
| Dec 2024 | 14.16% | - | - | - | 85.84% |
| Sep 2024 | 28.36% | - | - | - | 71.64% |